Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Factors Affecting the Results of Treatment of Patients With Colorectal Cancer

ABSTRACT: The study attempts to quantify the relative risks for mortality, anastomotic leakage and other early and late postoperative complications, recurrence rate, cancer-specific survival, recurrence-free survival after colorectal surgery for patients with colorectal cancer depending on the localization of the tumor.

DISEASE(S): Adenocarcinoma,Colorectal Adenocarcinoma,Rectal Neoplasms,Colorectal Neoplasms Malignant,Colon Cancer,Colorectal Cancer,Colorectal Neoplasms,Rectal Cancer,Rectal Adenocarcinoma,Colonic Neoplasms,Neoplasms

PROVIDER: 92971 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

ACCESS DATA

Json Xml

Similar Datasets

Molecular signaling distinguishes early from late recurrences in ER positive breast cancer

Project description:Unlike many other cancers, estrogen receptor-alpha (ER+) breast cancers are associated with cumulative risks of recurrence and death that persist for decades. We show that molecular differences between breast cancers that recur at distant sites early (² 3 years) or late (³ 5 years) support a robust molecular predictor of recurrence with Tamoxifen therapy and provide novel insights into the signaling features that differ between these recurrent cancers. We applied a support vector machine with recursive feature elimination to gene expression microarray data using a training-internal crossvalidation workflow that minimizes the gene selection bias problem. The resulting predictor was validated in an independent data set. Performance of the predictor suggests that it is possible to identify patients at increased risk of experiencing an early recurrence who require other treatments to prevent early metastasis. We implemented a Metropolis Sampling algorithm as a random walk to identify the protein-protein interactions (PPI) most closely associated with ER in 8 PPI databases. We then walked the gene expression data for the top PPIs to discover a signaling network driving early and late recurrent breast cancers. Consensus features between the training and validation datasets define a complex and highly connected network with major interactions among nodes including AR, CALD1, CALM(1,2,3), CDK1, EGFR, ESR1, ESR2, MAPK1, and SRC. The complexity illustrates the challenges in directing single agent or simple combination therapies to improve overall survival in ER+ breast cancers that will recur but also suggests potentially novel interventions to address this challenge. 49 independent samples (breast tumors) were arrayed

2015-04-15 | E-GEOD-46222 | biostudies-arrayexpress

Transcription profiling of human liver cancer samples

Project description:The identification of HCC patients with different risks of recurrence by incorporating the status of clinicopathological features available at diagnosis and gene expression profiling associated with recurrence

2007-11-12 | E-TABM-292 | biostudies-arrayexpress

Discovery of Novel Serum Peptide Biomarkers for CCA Recurrence Through MALDI-TOF and LC-MSMS Peptidome Analysis

Project description:Cholangiocarcinoma (CCA) is an aggressive cancer originating from bile duct epithelial cells, with a high rate of recurrence following surgical resection. Recurrence is categorized as early linked to aggressive tumor biology than late recurrence. This study aimed to identify novel peptide mass fingerprints (PMFs) and potential biomarker penel in the serum of CCA patients with early and late recurrence using mass spectrometry.

2025-10-31 | PXD057396 | JPOST Repository

Molecular signaling distinguishes early from late recurrences in ER positive breast cancer

2015-04-15 | GSE46222 | GEO

Project description:Cell survival enabled by leakage of a labile metabolic intermediate

| PRJNA839218 | ENA

Differential Localization of β-catenin Protein in CTNNB1 mutant Endometrial Cancers Results in Distinct Transcriptional Profiles

Project description:CTNNB1 exon 3 mutation is a well-established driver of nearly 30% of endometrioid endometrial cancers (EEC), and this is associated with worse patient survival. The purpose of this study was to determine downstream gene expression in these cancers with nuclear or membrane/cytoplasmic mutant b-catenin protein localization. We determined that EECs with exon 3 CTNNB1 mutations have variable b-catenin localization, and this is associated with profoundly distinct foci of gene expression within the same cancer.

2025-05-12 | GSE278479 | GEO

Identification of Serum Metabolite Biomarkers and Metabolic Reprogramming Mechanisms to Predict Recurrence in Cholangiocarcinoma

Project description:Cholangiocarcinoma (CCA) has high recurrence rates that severely limit long-term survival. Effective tools for accurate recurrence monitoring and diagnosis remain lacking. Metabolic reprogramming, a key driver of CCA growth and recurrence, is underutilized in cancer screening and management. This study aimed to identify metabolite-based biomarkers to evaluate recurrence severity, enhance disease management, and elucidate the molecular mechanisms underlying CCA recurrence.

2025-03-19 | PXD060214 | JPOST Repository

MicroRNA profiling of human stage I non-small cell lung cancer to quantify microRNA changes associated with disease recurrence

Project description:Expression of 752 microRNAs in 77 cases of stage I non-small cell lung cancer was examined using a locked nucleic acid microarray to quantify microRNA changes associated with recurrence of the disease after surgical resection.

2010-04-07 | E-TABM-727 | biostudies-arrayexpress

Laser-assisted pulmonary metastasectomy increases the chance of long-term survival in patients with colorectal cancer

Project description:Interventions: Group 1: In this retrospective analysis, the following patient data are analyzed to compare the laser-assisted versus non-laser-assisted lung metastasisctomy with respect to long-term survival: Age, sex, date of primary surgery, date of lung metastasectomy, localization of the metastasis, TNM staging, existence of extrapulmonal metastasis, neoadjuvant/adjuvant systemic treatments (chemotherapy, radiotherapy), date of recurrent surgery, surgical technique, surgical access, extent of resection, number of resected lung metastases, lung function data, number of dissected lymph nodes, resection margins, duration of hospitalisation, postoperative complications, date of recurrence, localization of recurrence, treatment at recurrence, date of death Primary outcome(s): overall survival Study Design: Allocation: ; Masking: ; Control: ; Assignment: ; Study design purpose: treatment

| 2432964 | ecrin-mdr-crc

Drosophila melanogaster

Project description:Kc167 Mcm2-7 Localization in Late S Phase

| PRJNA269389 | ENA